QOP
NVAX icon

Quinn Opportunity Partners’s Novavax NVAX Stock Holding History

Quinn Opportunity Partners’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-190,118
Closed -$1.2M – 376
2025
Q2 		$1.2M Buy
190,118
+74,057
+64% +$490K 0.1% 172
2025
Q1 		$744K Sell
116,061
-20,000
-15% -$165K 0.05% 238
2024
Q4 		$1.09M Buy
136,061
+125,000
+1,130% +$1.21M 0.07% 193
2024
Q3 		$140K Buy
+11,061
New +$143K 0.01% 256
2024
Q2 		– Sell
-255,001
Closed -$1.22M – 306
2024
Q1 		$1.22M Hold
255,001
– – 0.13% 121
2023
Q4 		$1.22M Buy
255,001
+40,000
+19% +$245K 0.13% 111
2023
Q3 		$1.56M Buy
+215,001
New +$1.72M 0.2% 96
2023
Q2 		– Sell
-507,886
Closed -$3.52M – 230
2023
Q1 		$3.52M Buy
+507,886
New +$4.67M 0.35% 61

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quinn Opportunity Partners's NVAX Position: Q3 2025 in Review

Quinn Opportunity Partners sold out of Novavax (NVAX) in Q3 2025, closing a stake of 190,118 shares — an estimated $1.2M sold.

Quinn Opportunity Partners first reported a position in NVAX in Q1 2023 and held it in 8 quarters. The position peaked at $3.52M in Q1 2023. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • Quinn Opportunity Partners reported no remaining Novavax position as of Q3 2025 after selling out during the quarter.
  • Quinn Opportunity Partners sold 190,118 Novavax shares in Q3 2025, an estimated $1.2M.
  • Quinn Opportunity Partners first reported a position in Novavax in Q1 2023 and held it in 8 quarters.
  • Quinn Opportunity Partners's Novavax position peaked at $3.52M in Q1 2023.
  • 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on Quinn Opportunity Partners's 13F filing for Q3 2025, filed 13 Nov 2025.